25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biostar Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Biostar Pharmaceuticals Inc together

I guess you are interested in Biostar Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biostar Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biostar Pharmaceuticals Inc

I send you an email if I find something interesting about Biostar Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Biostar Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biostar Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$13.98
Expected worth in 1 year
$2.78
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$-11.20
Return On Investment
-11,202,775.7%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biostar Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-5.44 - $9.90
Total Value Per Share
$8.54 - $23.89

2.2. Growth of Biostar Pharmaceuticals Inc (5 min.)




Is Biostar Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$36.8m$44.2m-$7.3m-20.0%

How much money is Biostar Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.6m-$25.1m$19.4m340.7%
Net Profit Margin-239.0%-92.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Biostar Pharmaceuticals Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biostar Pharmaceuticals Inc?

Welcome investor! Biostar Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Biostar Pharmaceuticals Inc.

First you should know what it really means to hold a share of Biostar Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Biostar Pharmaceuticals Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biostar Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biostar Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $13.98. Based on the TTM, the Book Value Change Per Share is $-2.80 per quarter. Based on the YOY, the Book Value Change Per Share is $-10.64 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biostar Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.16-2,160,779.1%-2.16-2,160,779.1%-9.52-9,522,469.7%-3.42-3,424,175.9%0.11109,454.1%
Usd Book Value Change Per Share-2.80-2,800,693.9%-2.80-2,800,693.9%-10.64-10,643,985.5%-3.00-2,997,320.9%1.401,398,427.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-2.80-2,800,693.9%-2.80-2,800,693.9%-10.64-10,643,985.5%-3.00-2,997,320.9%1.401,398,427.0%
Usd Price Per Share2.93-2.93-2.81-7.08-20.11-
Price to Earnings Ratio-1.36--1.36--0.29-9.82-9.24-
Price-to-Total Gains Ratio-1.05--1.05--0.26-1.52-3.96-
Price to Book Ratio0.21-0.21-0.17-0.32-1.07-
Price-to-Total Gains Ratio-1.05--1.05--0.26-1.52-3.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-2.80-3.00
Usd Total Gains Per Share-2.80-3.00
Gains per Quarter (10000000 shares)-28,006,939.20-29,973,208.60
Gains per Year (10000000 shares)-112,027,756.82-119,892,834.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-112027757-1120277670-119892834-119892844
20-224055514-2240555240-239785669-239785678
30-336083270-3360832810-359678503-359678512
40-448111027-4481110380-479571338-479571346
50-560138784-5601387950-599464172-599464180
60-672166541-6721665520-719357007-719357014
70-784194298-7841943090-839249841-839249848
80-896222055-8962220660-959142675-959142682
90-1008249811-10082498230-1079035510-1079035516
100-1120277568-11202775800-1198928344-1198928350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.03.00.070.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.03.00.070.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.03.00.070.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biostar Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.801-2.8010%-10.644+280%-2.997+7%1.398-300%
Book Value Per Share--13.98413.9840%16.785-17%20.782-33%18.634-25%
Current Ratio--1.3101.3100%2.278-42%3.860-66%4.348-70%
Debt To Asset Ratio--0.1320.1320%0.138-4%0.126+5%0.135-2%
Debt To Equity Ratio--0.1520.1520%0.160-5%0.146+4%0.158-4%
Dividend Per Share----0%-0%-0%-0%
Eps---2.161-2.1610%-9.522+341%-3.424+58%0.109-2074%
Free Cash Flow Per Share--1.8631.8630%2.206-16%1.174+59%1.263+48%
Free Cash Flow To Equity Per Share--2.3982.3980%2.145+12%1.727+39%1.801+33%
Gross Profit Margin--1.2051.2050%1.344-10%-3.471+388%-1.736+244%
Intrinsic Value_10Y_max--9.902--------
Intrinsic Value_10Y_min---5.441--------
Intrinsic Value_1Y_max--1.325--------
Intrinsic Value_1Y_min--0.748--------
Intrinsic Value_3Y_max--3.727--------
Intrinsic Value_3Y_min--1.141--------
Intrinsic Value_5Y_max--5.823--------
Intrinsic Value_5Y_min--0.318--------
Market Cap263.719-2929900%7726966.7007726966.7000%7405229.520+4%18680799.084-59%53036000.652-85%
Net Profit Margin---2.390-2.3900%-0.926-61%-0.725-70%-0.263-89%
Operating Margin---1.286-1.2860%-0.401-69%-0.369-71%-0.053-96%
Operating Ratio--2.4952.4950%1.401+78%1.420+76%1.079+131%
Pb Ratio0.000-2929900%0.2100.2100%0.167+25%0.321-35%1.066-80%
Pe Ratio0.000+100%-1.356-1.3560%-0.295-78%9.823-114%9.240-115%
Price Per Share0.000-2929900%2.9302.9300%2.808+4%7.084-59%20.111-85%
Price To Free Cash Flow Ratio0.000-2929900%1.5731.5730%1.273+24%10.298-85%14.963-89%
Price To Total Gains Ratio0.000+100%-1.046-1.0460%-0.264-75%1.520-169%3.963-126%
Quick Ratio--1.2801.2800%2.245-43%3.484-63%3.919-67%
Return On Assets---0.134-0.1340%-0.489+265%-0.167+25%0.022-719%
Return On Equity---0.155-0.1550%-0.567+267%-0.198+28%0.025-728%
Total Gains Per Share---2.801-2.8010%-10.644+280%-2.997+7%1.398-300%
Usd Book Value--36879177.00036879177.0000%44265139.000-17%54805070.800-33%49141141.500-25%
Usd Book Value Change Per Share---2.801-2.8010%-10.644+280%-2.997+7%1.398-300%
Usd Book Value Per Share--13.98413.9840%16.785-17%20.782-33%18.634-25%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---2.161-2.1610%-9.522+341%-3.424+58%0.109-2074%
Usd Free Cash Flow--4912665.0004912665.0000%5817738.000-16%3096470.800+59%3330083.200+48%
Usd Free Cash Flow Per Share--1.8631.8630%2.206-16%1.174+59%1.263+48%
Usd Free Cash Flow To Equity Per Share--2.3982.3980%2.145+12%1.727+39%1.801+33%
Usd Market Cap263.719-2929900%7726966.7007726966.7000%7405229.520+4%18680799.084-59%53036000.652-85%
Usd Price Per Share0.000-2929900%2.9302.9300%2.808+4%7.084-59%20.111-85%
Usd Profit---5698385.000-5698385.0000%-25112562.000+341%-9030202.400+58%555596.700-1126%
Usd Revenue--2384492.0002384492.0000%27129609.000-91%38595517.200-94%46827511.600-95%
Usd Total Gains Per Share---2.801-2.8010%-10.644+280%-2.997+7%1.398-300%
 EOD+4 -4MRQTTM+0 -0YOY+17 -175Y+19 -1510Y+12 -22

3.3 Fundamental Score

Let's check the fundamental score of Biostar Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-2.390
Operating Margin (MRQ)Greater than0-1.286
Quick Ratio (MRQ)Greater than11.280
Current Ratio (MRQ)Greater than11.310
Debt to Asset Ratio (MRQ)Less than10.132
Debt to Equity Ratio (MRQ)Less than10.152
Return on Equity (MRQ)Greater than0.15-0.155
Return on Assets (MRQ)Greater than0.05-0.134
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Biostar Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Biostar Pharmaceuticals Inc

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-08-30 04:06:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biostar Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -239.0% means that $-2.39 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biostar Pharmaceuticals Inc:

  • The MRQ is -239.0%. The company is making a huge loss. -2
  • The TTM is -239.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-239.0%TTM-239.0%0.0%
TTM-239.0%YOY-92.6%-146.4%
TTM-239.0%5Y-72.5%-166.4%
5Y-72.5%10Y-26.3%-46.2%
4.3.1.2. Return on Assets

Shows how efficient Biostar Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -13.4% Return on Assets means that Biostar Pharmaceuticals Inc generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biostar Pharmaceuticals Inc:

  • The MRQ is -13.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-13.4%0.0%
TTM-13.4%YOY-48.9%+35.5%
TTM-13.4%5Y-16.7%+3.3%
5Y-16.7%10Y2.2%-18.9%
4.3.1.3. Return on Equity

Shows how efficient Biostar Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -15.5% Return on Equity means Biostar Pharmaceuticals Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biostar Pharmaceuticals Inc:

  • The MRQ is -15.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.5%TTM-15.5%0.0%
TTM-15.5%YOY-56.7%+41.3%
TTM-15.5%5Y-19.8%+4.3%
5Y-19.8%10Y2.5%-22.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biostar Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biostar Pharmaceuticals Inc is operating .

  • Measures how much profit Biostar Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -128.6% means the company generated $-1.29  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biostar Pharmaceuticals Inc:

  • The MRQ is -128.6%. The company is operating very inefficient. -2
  • The TTM is -128.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-128.6%TTM-128.6%0.0%
TTM-128.6%YOY-40.1%-88.5%
TTM-128.6%5Y-36.9%-91.7%
5Y-36.9%10Y-5.3%-31.6%
4.3.2.2. Operating Ratio

Measures how efficient Biostar Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.49 means that the operating costs are $2.49 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biostar Pharmaceuticals Inc:

  • The MRQ is 2.495. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.495. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.495TTM2.4950.000
TTM2.495YOY1.401+1.094
TTM2.4955Y1.420+1.075
5Y1.42010Y1.079+0.341
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biostar Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biostar Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.31 means the company has $1.31 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biostar Pharmaceuticals Inc:

  • The MRQ is 1.310. The company is just able to pay all its short-term debts.
  • The TTM is 1.310. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.310TTM1.3100.000
TTM1.310YOY2.278-0.968
TTM1.3105Y3.860-2.550
5Y3.86010Y4.348-0.488
4.4.3.2. Quick Ratio

Measures if Biostar Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.28 means the company can pay off $1.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biostar Pharmaceuticals Inc:

  • The MRQ is 1.280. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.280. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.280TTM1.2800.000
TTM1.280YOY2.245-0.964
TTM1.2805Y3.484-2.204
5Y3.48410Y3.919-0.435
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biostar Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biostar Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biostar Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Biostar Pharmaceuticals Inc assets are financed with 13.2% credit (debt) and the remaining percentage (100% - 13.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biostar Pharmaceuticals Inc:

  • The MRQ is 0.132. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.132. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.1320.000
TTM0.132YOY0.138-0.006
TTM0.1325Y0.126+0.006
5Y0.12610Y0.135-0.008
4.5.4.2. Debt to Equity Ratio

Measures if Biostar Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 15.2% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biostar Pharmaceuticals Inc:

  • The MRQ is 0.152. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.152. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.1520.000
TTM0.152YOY0.160-0.008
TTM0.1525Y0.146+0.006
5Y0.14610Y0.158-0.012
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biostar Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Biostar Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.36 means the investor is paying $-1.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biostar Pharmaceuticals Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.356. Based on the earnings, the company is expensive. -2
  • The TTM is -1.356. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-1.356+1.356
MRQ-1.356TTM-1.3560.000
TTM-1.356YOY-0.295-1.061
TTM-1.3565Y9.823-11.179
5Y9.82310Y9.240+0.582
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biostar Pharmaceuticals Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.573. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.573. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.000MRQ1.573-1.573
MRQ1.573TTM1.5730.000
TTM1.573YOY1.273+0.300
TTM1.5735Y10.298-8.726
5Y10.29810Y14.963-4.664
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biostar Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Biostar Pharmaceuticals Inc:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 0.210. Based on the equity, the company is cheap. +2
  • The TTM is 0.210. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.210-0.210
MRQ0.210TTM0.2100.000
TTM0.210YOY0.167+0.042
TTM0.2105Y0.321-0.111
5Y0.32110Y1.066-0.745
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2012-12-312013-12-312014-12-312015-12-312016-12-31
Retained Earnings  23,23042023,6504,62028,270-25,1133,157-5,698-2,541



6.2. Latest Balance Sheet

Balance Sheet of 2016-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets42,502
Total Liabilities5,623
Total Stockholder Equity36,879
 As reported
Total Liabilities 5,623
Total Stockholder Equity+ 36,879
Total Assets = 42,502

Assets

Total Assets42,502
Total Current Assets7,365
Long-term Assets35,137
Total Current Assets
Cash And Cash Equivalents 173
Net Receivables 7,025
Inventory 167
Other Current Assets 0
Total Current Assets  (as reported)7,365
Total Current Assets  (calculated)7,365
+/-0
Long-term Assets
Property Plant Equipment 5,867
Intangible Assets 5,607
Other Assets 23,664
Long-term Assets  (as reported)35,137
Long-term Assets  (calculated)35,137
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,623
Long-term Liabilities5,168
Total Stockholder Equity36,879
Total Current Liabilities
Short-term Debt 2,326
Short Long Term Debt 2,326
Accounts payable 2,842
Other Current Liabilities 455
Total Current Liabilities  (as reported)5,623
Total Current Liabilities  (calculated)7,949
+/- 2,326
Long-term Liabilities
Long-term Liabilities  (as reported)5,168
Long-term Liabilities  (calculated)0
+/- 5,168
Total Stockholder Equity
Common Stock3
Retained Earnings Total Equity-2,541
Accumulated Other Comprehensive Income 8,035
Other Stockholders Equity 31,382
Total Stockholder Equity (as reported)36,879
Total Stockholder Equity (calculated)36,879
+/-0
Other
Cash and Short Term Investments 173
Common Stock Shares Outstanding 2,297
Common Stock Total Equity3
Liabilities and Stockholders Equity 42,502
Net Debt 2,152
Net Tangible Assets 31,272
Net Working Capital 1,742
Property Plant and Equipment Gross 5,867
Short Long Term Debt Total 2,326



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
20,247
28,998
47,010
68,087
83,062
70,475
67,564
81,247
51,364
42,502
42,50251,36481,24767,56470,47583,06268,08747,01028,99820,247
   > Total Current Assets 
6,636
15,701
30,222
43,350
60,509
41,974
35,986
43,633
16,167
7,365
7,36516,16743,63335,98641,97460,50943,35030,22215,7016,636
       Cash And Cash Equivalents 
2,286
758
8,578
13,211
16,972
1,759
80
1,685
39
173
173391,685801,75916,97213,2118,5787582,286
       Net Receivables 
4,123
11,701
19,803
28,539
35,034
35,722
31,639
36,853
15,894
7,025
7,02515,89436,85331,63935,72235,03428,53919,80311,7014,123
       Inventory 
208
316
340
352
1,373
847
830
674
235
167
1672356748308471,373352340316208
       Other Current Assets 
18
2,927
1,500
1,248
7,130
3,646
3,436
4,421
0
0
004,4213,4363,6467,1301,2481,5002,92718
   > Long-term Assets 
13,611
13,296
16,789
24,737
22,553
28,501
31,579
37,614
35,196
35,137
35,13735,19637,61431,57928,50122,55324,73716,78913,29613,611
       Property Plant Equipment 
6,207
5,930
4,341
5,959
7,380
6,981
7,729
8,483
6,811
5,867
5,8676,8118,4837,7296,9817,3805,9594,3415,9306,207
       Intangible Assets 
7,404
7,366
11,132
11,065
10,407
9,136
17,134
13,270
6,879
5,607
5,6076,87913,27017,1349,13610,40711,06511,1327,3667,404
       Other Assets 
0
0
1,316
7,713
4,766
12,384
6,716
15,861
21,507
23,664
23,66421,50715,8616,71612,3844,7667,7131,31600
> Total Liabilities 
3,955
5,725
6,091
7,587
6,660
12,703
4,792
8,912
7,098
5,623
5,6237,0988,9124,79212,7036,6607,5876,0915,7253,955
   > Total Current Liabilities 
3,955
5,725
6,091
7,587
6,660
12,703
4,792
8,912
7,098
5,623
5,6237,0988,9124,79212,7036,6607,5876,0915,7253,955
       Short-term Debt 
520
0
0
0
787
6,341
0
3,095
2,773
2,326
2,3262,7733,09506,341787000520
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
2,326
2,326000000000
       Accounts payable 
538
2,192
3,559
3,991
3,334
5,732
4,447
5,001
4,153
2,842
2,8424,1535,0014,4475,7323,3343,9913,5592,192538
       Other Current Liabilities 
2,413
3,533
2,531
3,596
2,539
630
344
383
59
455
455593833446302,5393,5962,5313,5332,413
   > Long-term Liabilities 
0
0
0
0
0
12,073
4,447
8,096
6,927
5,168
5,1686,9278,0964,44712,07300000
> Total Stockholder Equity
16,291
23,273
40,920
60,500
76,402
57,773
62,773
72,335
44,265
36,879
36,87944,26572,33562,77357,77376,40260,50040,92023,27316,291
   Common Stock
22
23
23
27
28
10
13
15
2
3
321513102827232322
   Retained Earnings 
6,452
10,997
17,549
37,791
43,474
23,230
23,650
28,270
3,157
-2,541
-2,5413,15728,27023,65023,23043,47437,79117,54910,9976,452
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
9,146
12,016
22,662
20,707
28,917
23,267
25,384
30,304
30,317
31,382
31,38230,31730,30425,38423,26728,91720,70722,66212,0169,146



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2016-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,384
Cost of Revenue-1,469
Gross Profit915915
 
Operating Income (+$)
Gross Profit915
Operating Expense-4,479
Operating Income-3,564-3,564
 
Operating Expense (+$)
Research Development1,144
Selling General Administrative2,431
Selling And Marketing Expenses1,169
Operating Expense4,4794,745
 
Net Interest Income (+$)
Interest Income1
Interest Expense-206
Other Finance Cost-0
Net Interest Income-205
 
Pretax Income (+$)
Operating Income-3,564
Net Interest Income-205
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,045-4,083
EBIT - interestExpense = -3,272
-3,045
-5,492
Interest Expense206
Earnings Before Interest and Taxes (EBIT)-3,066-2,839
Earnings Before Interest and Taxes (EBITDA)-1,924
 
After tax Income (+$)
Income Before Tax-3,045
Tax Provision-2,653
Net Income From Continuing Ops-5,698-5,698
Net Income-5,698
Net Income Applicable To Common Shares-5,698
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring-265
Other Operating Expenses5,949
Total Other Income/Expenses Net519205
 

Technical Analysis of Biostar Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biostar Pharmaceuticals Inc. The general trend of Biostar Pharmaceuticals Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biostar Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biostar Pharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Biostar Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biostar Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biostar Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biostar Pharmaceuticals Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biostar Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biostar Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biostar Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biostar Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiostar Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biostar Pharmaceuticals Inc. The current adx is 100.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Biostar Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biostar Pharmaceuticals Inc. The current sar is 0.00025424.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biostar Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biostar Pharmaceuticals Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Biostar Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartBiostar Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biostar Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biostar Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biostar Pharmaceuticals Inc Daily Stochastic Oscillator ChartBiostar Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biostar Pharmaceuticals Inc. The current cci is -66.66666667.

Biostar Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartBiostar Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biostar Pharmaceuticals Inc. The current cmo is 0.

Biostar Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartBiostar Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biostar Pharmaceuticals Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Biostar Pharmaceuticals Inc Daily Williams %R ChartBiostar Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biostar Pharmaceuticals Inc.

Biostar Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biostar Pharmaceuticals Inc. The current atr is 0.

Biostar Pharmaceuticals Inc Daily Average True Range (ATR) ChartBiostar Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biostar Pharmaceuticals Inc. The current obv is 879.00.

Biostar Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartBiostar Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biostar Pharmaceuticals Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Biostar Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartBiostar Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biostar Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Biostar Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biostar Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biostar Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Biostar Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biostar Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biostar Pharmaceuticals Inc

I send you an email if I find something interesting about Biostar Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biostar Pharmaceuticals Inc.

Receive notifications about Biostar Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.